185 related articles for article (PubMed ID: 20368536)
61. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis.
Chen C; Xia HS; Gong YP; Peng J; Peng CW; Hu MB; Zhu XB; Pang DW; Sun SR; Li Y
Biomaterials; 2010 Nov; 31(33):8818-25. PubMed ID: 20723971
[TBL] [Abstract][Full Text] [Related]
62. Clinicopathologic features associated with long-term survival in node-negative breast cancer patients.
Kato T; Kimura T; Miyakawa R; Tanaka S; Kamio T; Yamamoto K; Hamano K; Aiba M; Kawakami M
Surg Today; 1996; 26(2):105-14. PubMed ID: 8919280
[TBL] [Abstract][Full Text] [Related]
63. [Update on current care guidelines. Diagnostics and follow-up of breast cancers].
Duodecim; 2005; 121(1):111-2. PubMed ID: 15714657
[No Abstract] [Full Text] [Related]
64. [Conservative surgical treatment in breast cancer].
Loffredo V
Contracept Fertil Sex; 1993 Feb; 21(2):157-61. PubMed ID: 7951607
[TBL] [Abstract][Full Text] [Related]
65. High-intensity focused ultrasound effect in breast cancer nodal metastasis.
Orgera G; Curigliano G; Krokidis M; Bonomo G; Monfardini L; Della Vigna P; Zampino MG; Orsi F
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):447-9. PubMed ID: 20162283
[No Abstract] [Full Text] [Related]
66. Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database.
McGowan PM; Duffy MJ
Ann Oncol; 2008 Sep; 19(9):1566-72. PubMed ID: 18503039
[TBL] [Abstract][Full Text] [Related]
67. Radiation therapy for breast cancer: buyer beware.
Witteles RM
J Am Coll Cardiol; 2011 Jan; 57(4):453-4. PubMed ID: 21251586
[No Abstract] [Full Text] [Related]
68. Prophylactic mastectomy of the contralateral breast.
Morrow M
Breast; 2011 Oct; 20 Suppl 3():S108-10. PubMed ID: 22015275
[No Abstract] [Full Text] [Related]
69. Breast cancer in Western Australia: clinical practice and clinical guidelines.
McEvoy SP; Ingram DM; Byrne MJ; Joseph DJ; Dewar J; Trotter J; Harper C; Haworth C; Harvey JM; Sterrett GF; Jamrozik K; Fritschi L
Med J Aust; 2004 Sep; 181(6):305-9. PubMed ID: 15377239
[TBL] [Abstract][Full Text] [Related]
70. Inflammatory breast cancer: current concepts in local management.
Bristol IJ; Buchholz TA
Breast Dis; 2005-2006; 22():75-83. PubMed ID: 16761358
[TBL] [Abstract][Full Text] [Related]
71. Treatment-associated toxicities reported by patients with early-stage invasive breast cancer.
Friese CR; Harrison JM; Janz NK; Jagsi R; Morrow M; Li Y; Hamilton AS; Ward KC; Kurian AW; Katz SJ; Hofer TP
Cancer; 2017 Jun; 123(11):1925-1934. PubMed ID: 28117882
[TBL] [Abstract][Full Text] [Related]
72. Quality of life assessment.
Shimozuma K
Breast Cancer; 2002; 9(2):100-6. PubMed ID: 12016388
[TBL] [Abstract][Full Text] [Related]
73. Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells.
Kirchner EM; Gerhards R; Voigtmann R
Ann Oncol; 2002 Jul; 13(7):1044-8. PubMed ID: 12176782
[TBL] [Abstract][Full Text] [Related]
74. Do we need better prognostic factors in node-negative breast cancer? Pro:
Thomssen C; Jänicke F
Eur J Cancer; 2000 Feb; 36(3):293-8. PubMed ID: 10708928
[No Abstract] [Full Text] [Related]
75. Images in clinical medicine. Cerebral metastases in breast cancer.
Rouse H; Dawson SJ
N Engl J Med; 2005 Oct; 353(16):1724. PubMed ID: 16236743
[No Abstract] [Full Text] [Related]
76. Follow-up of Patients Treated for pT1aN0M0 Breast Cancer: 10-year Survival and Prognostic Factors.
Crochet P; Molinari N; Darmon JC; Cutuli B; Serin D
Breast J; 2016 May; 22(3):363-5. PubMed ID: 26932725
[No Abstract] [Full Text] [Related]
77. Bone marrow micrometastases in breast cancer.
Jeruss JS; Kuerer HM
N Engl J Med; 2005 Nov; 353(20):2191; author reply 2191. PubMed ID: 16291991
[No Abstract] [Full Text] [Related]
78. Diffuse large B-cell lymphoma of the breast: a distinct entity?
Bierman PJ; Villanueva ML; Armitage JO
Ann Oncol; 2008 Feb; 19(2):201-2. PubMed ID: 18187483
[No Abstract] [Full Text] [Related]
79. Breast cancer: specialists do make a difference.
Copeland EM
Ann Surg Oncol; 2003 Jul; 10(6):589-90. PubMed ID: 12839840
[No Abstract] [Full Text] [Related]
80. From genome to bedside: are we lost in translation?
Hayes DF
Breast; 2013 Aug; 22 Suppl 2():S22-6. PubMed ID: 24074786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
